Marinobufagenin, left ventricular geometry and cardiac dysfunction in end-stage kidney disease patients-Reference-Cited by-同舟云学术

Marinobufagenin, left ventricular geometry and cardiac dysfunction in end-stage kidney disease patients

Published:2022-03-10 Issue:10 Volume:54 Page:2581-2589
ISSN:1573-2584
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Bolignano Davide^ORCID,De Rosa Salvatore,Greco Marta,Presta Pierangela,Patella Gemma,Crugliano Giuseppina,Sabatino Jolanda,Strangio Antonio,Romano Letizia Rosa,Comi Alessandro,Cianfrone Paola,Andreucci Michele,Dragone Francesco,Indolfi Ciro,Foti Daniela Patrizia,Coppolino Giuseppe

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

https://link.springer.com/content/pdf/10.1007/s11255-022-03161-0.pdf

Reference30 articles.

1. de Albuquerque Suassuna PG, Sanders-Pinheiro H, de Paula RB (2018) Uremic cardiomyopathy: a new piece in the chronic kidney disease-mineral and bone disorder puzzle. Front Med (Lausanne) 5:206

2. Zoccali C, Benedetto FA, Mallamaci F et al (2004) Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 65(4):1492–1498

3. Parfrey PS, Harnett JD, Griffiths SM et al (1990) The clinical course of left ventricular hypertrophy in dialysis patients. Nephron 55(2):114–120

4. Garikapati K, Goh D, Khanna S et al (2021) Uraemic cardiomyopathy: a review of current literature. Clin Med Insights Cardiol 15:1179546821998347

5. Schoner W, Scheiner-Bobis G (2007) Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol 293(2):C509-536

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association between Echocardiographic Parameters of Heart Failure with Preserved Ejection Fraction and Fluid Status Biomarkers in Hemodialysis Patients;Diagnostics;2024-06-20

2. Chronic kidney disease associated cardiomyopathy: recent advances and future perspectives;Current Opinion in Nephrology & Hypertension;2024-01-05

3. Echocardiographic manifestations in end-stage renal disease;Heart Failure Reviews;2023-12-10

4. Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional Study;Medicina;2023-07-29

5. New Insights on the Role of Marinobufagenin from Bench to Bedside in Cardiovascular and Kidney Diseases;International Journal of Molecular Sciences;2023-07-06